Pentax Medical obtained a CE Mark for its DEC Duodenoscope.
VolitionRx is planning a European launch of its CRC screening product in 2018.
Immuron is making progress on its three clinical trials for IMM-124E, a nonalcoholic steatohepatitis and nonalcoholic fatty liver disease treatment.
More articles on gastroenterology:
GI leader to know: Dr. Francis Farraye of Boston Medical Center
Stock market week-in-review for 5 large GI companies — Sept. 11-15
Patient engagement, case conference less effective in IBD care than perceived
